Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2015
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 12 Nov 2015 New trial record